Raphas Co. Ltd (214260) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.045x

Based on the latest financial reports, Raphas Co. Ltd (214260) has a cash flow conversion efficiency ratio of -0.045x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.35 Billion ≈ $-913.95K USD) by net assets (₩29.85 Billion ≈ $20.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Raphas Co. Ltd (214260) balance sheet quality index to measure how much of total assets are equity-financed.

Raphas Co. Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Raphas Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Raphas Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Raphas Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Raphas Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sherritt International Corporation TO:S	0.024x
BII Railway Transportation Technology Holdings Company Limited F:CN6	-0.008x
FLUOGUIDE A/S DK -1 F:96X	-0.092x
Selangor Dredging Bhd KLSE:2224	0.216x
Ionic Rare EARTHS Ltd AU:IXR	-0.086x
Steppe Cement F:ST9	0.046x
LB Aluminium Bhd KLSE:9326	-0.024x
Genie Music Corporation KQ:043610	0.050x

Annual Cash Flow Conversion Efficiency for Raphas Co. Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Raphas Co. Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Raphas Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩30.71 Billion ≈ $20.81 Million	₩1.43 Billion ≈ $970.87K	0.047x	-71.96%
2024-12-31	₩29.36 Billion ≈ $19.90 Million	₩4.88 Billion ≈ $3.31 Million	0.166x	+397.25%
2023-12-31	₩32.31 Billion ≈ $21.89 Million	₩-1.81 Billion ≈ $-1.23 Million	-0.056x	+36.98%
2022-12-31	₩40.93 Billion ≈ $27.74 Million	₩-3.63 Billion ≈ $-2.46 Million	-0.089x	-639.31%
2021-12-31	₩52.36 Billion ≈ $35.48 Million	₩862.01 Million ≈ $584.17K	0.016x	-19.52%
2020-12-31	₩44.18 Billion ≈ $29.94 Million	₩903.85 Million ≈ $612.53K	0.020x	+135.31%
2019-12-31	₩47.83 Billion ≈ $32.42 Million	₩-2.77 Billion ≈ $-1.88 Million	-0.058x	-79.15%
2018-12-31	₩20.13 Billion ≈ $13.64 Million	₩-651.09 Million ≈ $-441.23K	-0.032x	+50.53%
2017-12-31	₩23.74 Billion ≈ $16.09 Million	₩-1.55 Billion ≈ $-1.05 Million	-0.065x	--

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology

Market Cap

$50.26 Million

₩74.16 Billion KRW

Market Cap Rank

#21826 Global

#1290 in Korea

Share Price

₩8820.00

Change (1 day)

+6.78%

52-Week Range

₩6720.00 - ₩15500.00

All Time High

₩75400.00